AMCP Research Institute

The Research Engine Behind AMCP

Evidence. Innovation. Impact.
The AMCP Research Institute (ARI) generates the evidence, insights, and innovations that advance patient care, inform policy decisions, strengthen managed care pharmacy practice, and support AMCP's mission to improve health outcomes.
People posing for picture
AMCP members attend the AMCP Winter Leadership event with Cate Lockhart, AMCP Chief Science Officer & Pam Pawloski, AMCP Principal Research Scientist
Who we are

The Research Behind AMCP's Thought Leadership

The AMCP Research Institute was established to elevate the role of research across managed care pharmacy and create practical evidence that informs decision-making.

Research generated through the AMCP Research Institute helps inform:
AMCP advocacy priorities
Professional practice initiatives
Managed care research agenda
Educational programming
Employer & payer engagement
Future managed care innovations
Looking Ahead

Building the Leading Research Organization for Managed Care Pharmacy

Our vision is to become the trusted source of evidence, innovation, and insights shaping the future of managed care pharmacy — through strategic partnerships, advanced data capabilities, and collaborative research.

Explore the AMCP Innovation Ecosystem

AMCP Ecosystem
Our Work

Featured Research

Biologics & Biosimilars Collective Intelligence Consortium (BBCIC)
Flagship
Click to expand

Generating trusted real-world evidence on biologics and biosimilars through collaborative research, data partnerships, and scientific expertise to support evidence-based decision-making across the health care ecosystem.

Recent Projects

  • FDA International Grant
  • Effect of COVID-19 pandemic on non-COVID related treatment in IBD
  • Adherence – algorithms, methods, and outcomes (literature review)
  • Biosimilar access and utilization (manuscript in preparation)
  • Patient Experiences with Biosimilars in IBD: a Qualitative Study
  • Survey of Biosimilar Market Sustainability
     

View Research

Real World Evidence Initiative (RWE)
Featured
Click to expand

Creating the standards, tools, and collaborations that help health care stakeholders use real-world evidence more confidently and consistently in decision-making.

Related Resources

Precision Medicine Initiative
Click to expand

Advancing the use of biomarker testing and precision medicine to ensure more personalized, evidence-based treatment decisions for patients.

Related Resources

Management of Mid-life Dementia Risk with a Medication Therapy Management Healthcare Improvement Initiative (MTM-MIND)
Click to expand

Exploring how medication therapy management can help reduce dementia risk and improve patient outcomes through earlier intervention and evidence-based care models.

Related Resources

Cardiometabolic Health Real-world Outcomes & Management Evaluation (CHROME)
Click to expand

Generating real-world evidence on cardiometabolic health outcomes to support better treatment decisions and health care management strategies.

Related Resources

 

By the Numbers

Research Driving Impact Today

24
Published manuscripts
73
Poster presentations
20
Active Projects
All data current as of November 20, 2026 | Includes ARI & BBCIC Activities
BBCIC

The Biologics & Biosimilars Collective Intelligence Consortium (BBCIC)

BBCIC is AMCP's dedicated biosimilars research arm — a public-private, non-proprietary consortium that generates real-world evidence on the safety and effectiveness of biologics, biosimilars, and other novel therapeutics.

By pooling de-identified data from participating health plans and integrated delivery systems, BBCIC produces scientifically rigorous evidence that builds clinician and payer confidence in biosimilar adoption.

Woman Scientist
What we're learning

Research Insights & Perspectives

AMCP Research Institute researchers share insights from active studies, emerging trends, and lessons from the forefront of managed care pharmacy.

Pam Pawloski Presenting Precision Medicine Poster
Research Insight

AMCP Research Rundown — Spotlight on Precision Medicine

AMCP Research Institute recently presented a poster on the Precision Medicine Initiative at ISPOR Europe 2026 in Vienna, Austria! Pam Pawloski presented, Biomarker Testing in NSCLC: A Landscape Assessment of Administrative Data, which examined how biomarker testing has changed over time.

RWE Arena
Research Insight

AMCP Research Rundown — New Look, Great Turnout at the RWE Arena

AMCP Research Institute (ARI) is looking back at a successful RWE Arena at AMCP Nexus 2026, complete with a fresh new look! The strong turnout and range of topics highlighted the growing interest in real-world evidence and the RWE Arena’s role in bringing researchers and health care decision-makers together to share practical insights and learn from one another.

AMCP Research Institute FDA Grant Biosimilars
Research Insight

AMCP Research Rundown — FDA-Funded Project to Inform Interchangeable Biosimilar Approvals

This BBCIC FDA-funded project is exploring how international real-world data from Italy and Denmark can inform biosimilar regulatory decisions. With the project nearing completion, the team recently shared early findings at ISPE 2026 and is preparing to meet with FDA colleagues to discuss the findings and implications.

RELATED AMCP RESOURCES
AMCP Membership

From Evidence to Action: AMCP is Your Professional Association Driving Real-World Impact

  • Learn through certificate programs, continuing education, and RWE Essentials training
  • Access trusted insights from JMCP, research reports, and white papers
  • Connect with experts at our National Meetings AMCP Nexus, Annual Meeting, webinars, and the Research Showcase
  • Apply evidence through practical toolkits and implementation frameworks
  • Advance professional practice across payer, employer, and healthcare organizations
  • Stay ahead of emerging trends shaping managed care pharmacy

Learn more about AMCP Membership.

AMCP Conference
Get Involved

Contact the AMCP Research Institute

What to learn more about the AMCP Research Institute? We'd love to hear from you!